GENDELL JEFFREY L
Q2 2023 13F-HR Holdings
Net value change ($000)
+221,429
(20.7%)
New positions
6
Sold out positions
5
Turnover %
1.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IESC | 157,346 | 32.0% |
| AVDL | 40,361 | 83.1% |
| BTU | 24,751 | 161.6% |
| BXC | 8,074 | 21.8% |
| AMR | 5,651 | 6.1% |
| TTI | 4,684 | 39.4% |
| PSCE | 3,511 | NEW |
| MHK | 3,347 | 17.2% |
| HP | 2,685 | 29.2% |
| SEELOS THERAPEUTICS, INC. | 2,673 | 76.3% |
Top Reduces (Value $000, Stocks/ETFs)
| LXU | -11,431 | -53.6% |
| CORE LABORATORIES N V | -4,841 | -100.0% |
| VATE | -4,671 | -41.2% |
| Invesco Exchange-Traded Fund Trust II | -3,841 | -100.0% |
| LBRT | -2,986 | -24.2% |
| PEBK | -2,851 | -42.1% |
| CMT | -2,277 | -55.6% |
| RIG | -2,226 | -100.0% |
| ASTL | -1,940 | -11.9% |
| XAIR | -1,344 | -26.8% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,501
(0.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|